Sagimet Biosciences Inc.SGMTNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+16.2%
5Y CAGR+36.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+16.2%/yr
Annual compound
5Y CAGR
+36.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.8x
Strong expansion
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$39.05M+1.6%
2024$38.44M+94.4%
2023$19.78M-20.6%
2022$24.92M+28.8%
2021$19.34M+136.4%
2020$8.18M-2.5%
2019$8.39M-